Amphastar Pharmaceuticals...
38.47
0.55 (1.45%)
At close: Jan 14, 2025, 3:59 PM
38.48
0.03%
After-hours Jan 14, 2025, 06:02 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11
Revenue 644.39M 498.99M 437.77M 349.85M 322.36M 294.67M 240.18M 255.16M 251.52M 210.46M 229.68M 204.32M 118.36M
Cost of Revenue 293.27M 250.13M 238.03M 206.51M 190.43M 187.68M 149.38M 150.98M 174.17M 159.21M 142.72M 114.02M 90.25M
Gross Profit 351.12M 248.86M 199.74M 143.34M 131.92M 106.98M 90.80M 104.19M 77.35M 51.26M 86.96M 90.30M 28.10M
Operating Income 196.99M 78.76M 43.13M -14.23M -39.00K -8.62M -895.00K 15.69M -6.90M -17.98M 17.49M 25.40M -33.55M
Interest Income 5.46M 1.32M 601.00K 642.00K 997.00K 456.00K 425.00K 270.00K 315.00K 243.00K 187.00K 242.00K 401.00K
Pretax Income 171.36M 116.04M 84.14M 4.64M 60.23M -9.93M 1.62M 14.95M -10.36M -18.15M 17.23M 25.88M -31.89M
Net Income 137.54M 91.39M 62.12M 1.10M 48.94M -5.74M 4.51M 10.53M -2.79M -10.70M 11.86M 18.09M 7.75M
Selling & General & Admin 80.39M 66.59M 68.92M 65.16M 63.11M 58.04M 50.92M 47.30M 46.97M 40.37M 36.32M 31.65M 30.53M
Research & Development 73.74M 74.77M 60.93M 67.23M 68.85M 57.56M 43.41M 41.20M 37.06M 28.43M 33.02M 31.16M 31.05M
Other Expenses n/a 8.54M 14.25M -6.32M 60.27M -1.30M 2.52M -746.00K -2.79M -165.00K 508.00K 1.02M 1.84M
Operating Expenses 154.13M 141.36M 129.85M 132.39M 131.96M 115.61M 94.33M 88.50M 84.04M 68.80M 69.34M 62.81M 61.58M
Interest Expense 27.16M 1.85M 885.00K 374.00K 119.00K 243.00K 826.00K 1.02M 987.00K 609.00K 958.00K 784.00K 584.00K
Selling & Marketing Expenses 28.85M 21.53M 17.49M 14.78M 12.83M 8.16M 6.46M 5.47M 5.47M 5.56M 5.35M 4.43M 4.10M
Cost & Expenses 447.41M 391.49M 367.88M 338.89M 322.40M 303.29M 243.71M 239.47M 258.21M 228.00M 212.06M 176.83M 151.83M
Income Tax 31.83M 23.48M 20.63M 3.54M 13.72M -3.27M -2.88M 4.41M -7.58M -7.45M 5.37M 7.78M -39.64M
Shares Outstanding (Basic) 48.27M 48.55M 47.78M 47.04M 46.98M 46.40M 46.11M 45.38M 44.96M 41.96M 8.00M 8.00M 8.00M
Shares Outstanding (Diluted) 53.00M 52.43M 49.78M 49.12M 49.91M 46.40M 48.37M 47.50M 44.96M 41.96M 8.00M 8.00M 8.00M
EPS (Basic) 2.85 1.88 1.30 0.02 1.04 -0.12 0.10 0.23 -0.06 -0.25 1.48 2.26 0.97
EPS (Diluted) 2.60 1.74 1.25 0.02 0.98 -0.12 0.09 0.22 -0.06 -0.25 1.48 2.26 0.97
EBITDA 240.29M 107.50M 111.78M 30.19M 81.47M 6.83M 11.90M 30.53M 3.88M -3.09M 30.69M 38.16M -20.15M
Depreciation & Amortization 41.78M 28.74M 26.75M 25.18M 21.12M 16.52M 15.81M 14.56M 13.25M 14.45M 13.08M 11.50M 11.15M